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Extracellular DNA, cell surface 
proteins and c‑di‑GMP promote 
biofilm formation in Clostridioides 
difficile
Lisa F. Dawson1*, Johann Peltier1,3, Catherine L. Hall1, Mark A. Harrison1, 
Maria Derakhshan1, Helen A. Shaw1,4, Neil F. Fairweather2 & Brendan W. Wren1
Clostridioides difficile is the leading cause of nosocomial antibiotic‑associated diarrhoea worldwide, 
yet there is little insight into intestinal tract colonisation and relapse. In many bacterial species, the 
secondary messenger cyclic‑di‑GMP mediates switching between planktonic phase, sessile growth 
and biofilm formation. We demonstrate that c‑di‑GMP promotes early biofilm formation in C. difficile 
and that four cell surface proteins contribute to biofilm formation, including two c‑di‑GMP regulated; 
CD2831 and CD3246, and two c‑di‑GMP‑independent; CD3392 and CD0183. We demonstrate that C. 
difficile biofilms are composed of extracellular DNA (eDNA), cell surface and intracellular proteins, 
which form a protective matrix around C. difficile vegetative cells and spores, as shown by a protective 
effect against the antibiotic vancomycin. We demonstrate a positive correlation between biofilm 
biomass, sporulation frequency and eDNA abundance in all five C. difficile lineages. Strains 630 
(RT012), CD305 (RT023) and M120 (RT078) contain significantly more eDNA in their biofilm matrix 
than strains R20291 (RT027) and M68 (RT017). DNase has a profound effect on biofilm integrity, 
resulting in complete disassembly of the biofilm matrix, inhibition of biofilm formation and reduced 
spore germination. The addition of exogenous DNase could be exploited in treatment of C. difficile 
infection and relapse, to improve antibiotic efficacy.
Clostridiodes difficile (formerly Clostridium difficile) is a spore-forming obligate anaerobe, responsible for the 
majority of nosocomial antibiotic-associated diarrhoea cases worldwide. Treatment with antibiotics for an under-
lying condition alters the intestinal microbiota, which results in susceptibility to colonisation with C. difficile1. 
Ingested spores, the etiological agent of C. difficile transmission, germinate in the small intestine upon exposure 
to conjugated and deconjugated bile  salts2, resulting in outgrowth of metabolically active vegetative cells, which 
produce toxins, TcdA and TcdB, responsible for damage of the host intestinal  tract3. Current data indicates that 
15–35% of patients suffering from C. difficile infection (CDI) relapse within two months post-treatment4, with 
increasing probability of relapse thereafter, indicating the presence of a potential reservoir of C. difficile re-seeding 
the intestinal tract of susceptible  patients5.
Many pathogenic bacteria aggregate and form biofilms, defined as communities of bacteria encased within a 
self-produced matrix, which provide a protective barrier against host defenses and  antimicrobials6. Biofilm for-
mation allows pathogens to attain a foothold in a given environment, such as a tissue or on an implanted  device7, 
which facilitate recurrent bacterial infections for various  pathogens8–10. Biofilm formation is a multifaceted 
process, divided into three stages; (1) attachment, (2) maturation and (3)  dispersal11. Active dispersal, in which 
planktonic cells are released from a biofilm matrix facilitates colonization of a subsequent  niche12 and contributes 
to disease  recurrence8–10. The structure and composition of a biofilm can vary between species, however, generally 
the biofilm matrix is comprised of a self-produced Extracellular Polymeric Substance (EPS), usually formed in 
three primary categories: (1) exopolysaccharide, (2) extracellular and cell surface proteins and (3) extracellular 
DNA (eDNA)13. Production and composition of the biofilm matrix within a species can depend on environmental 
 triggers11,14, for example, the opportunistic pathogen Pseudomonas aeruginosa produces either a mucoid biofilm, 
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with alginate as a key EPS component, or a non-mucoid biofilm, with the Psl and Pel exopolysaccharides as the 
predominant matrix  proteins11,15,16. Despite the presence of species-specific exopolysaccharides, eDNA forms a 
crucial part of the biofilm structure in a number of species, including P. aeruginosa17,18, Staphylococcus aureus19,20, 
Listeria monocytogenes21, and Streptococcus pneumoniae22.
To date, several studies have shown that C. difficile forms biofilms; including the formation of multicellular 
structures in vitro23–29, dual species  biofilms30, multispecies biofilms in a human  chemostat31,32, and the formation 
of mats and aggregates in vivo33–35. There is evidence that C. difficile biofilms are composed of DNA and protein 
surrounding adherent spores and vegetative cells, although the extent to which they contribute to biofilm for-
mation, biofilm integrity and dispersal remains to be  determined23–25,29. C. difficile genome searches have failed 
to identify putative genes encoding biofilm matrix proteins. In fact, most factors and components required by 
other biofilm-producing bacteria are not conserved in C. difficile28. Several genes have been attributed to biofilm 
formation in C. difficile, most notably, the sporulation master regulator spo0A23,25,29, the quorum sensing regulator 
luxS36,37, and the germination receptor sleC25, whose mutations significantly decrease biofilm formation. Con-
versely, inactivation of the chaperones dnaK and hfq38,39, the transcriptional regulators CD2214–CD2215 (double 
mutant)28 and the regulator of the SOS response network lexA40 increased biofilm formation. Mutation of genes 
encoding the cell surface protease cwp84 and the flagella filament fliC have been shown to both  positively36,41 
and  negatively26,36 impact biofilm biomass. This highlights that biofilm formation in C. difficile like other species 
is a multifaceted complex process.
In C. difficile and other bacteria, the secondary messenger c-di-GMP enhances biofilm formation and 
aggregation by inversely regulating aggregation and cell motility via the modulation of flagella and type IV pili 
 expression42–44. In other species c-di-GMP also regulates production of extracellular  polysaccharides45,46 and 
surface associated cell wall  proteins47, which form part of the biofilm matrix, as well as modulating the switch 
between motile and sessile lifestyle. Inactivation of the phosphodiesterase PcdA, which facilitates turnover of 
c-di-GMP, increases biofilm formation in C. difficile44. C. difficile encodes a number of cell surface associated 
proteins, including those covalently anchored to peptidoglycan within the cell wall via the single sortase,  SrtB48–51. 
CD2831 and CD3246 are cell surface proteins, which are cleaved and covalently anchored to m-DAP in the pep-
tidoglycan by  SrtB50,52–54. Under low-level c-di-GMP, the protease PPEP-1 is produced which cleaves CD2831 
and CD3246 from the  peptidoglycan55,56. Conversely under elevated levels of c-di-GMP, PPEP-1 is repressed and 
CD2831 is highly expressed, leading to the surface exposure of covalently anchored  CD283149 and  CD324654,55.
We investigated factors involved in biofilm formation in C. difficile including biomass structure, production 
and stability. We elucidated the role of c-di-GMP and four cell surface associated proteins, CD0183, CD2831, 
CD3246 and CD3392 in early biofilm formation in C. difficile and highlight the importance of eDNA in biofilm 
development, integrity and resistance to the anti-C. difficile antibiotic vancomycin. We identified that all five C. 
difficile lineages are dependent on eDNA for biofilm initiation, stability and biomass, which positively correlates 
with sporulation frequency. Herein, we present a model of biofilm formation, and a strategy to interfere with (1) 
attachment and (2) biofilm maturation for C. difficile, which potentially provides a non-microbicidal strategy to 
combine with current antibiotic therapies to reduce the reservoir of C. difficile.
Results
Visualization and composition of C. difficile biofilms. Clostridioides difficile strain 630, a ribotype 012 
(RT012) was grown on thermanox coverslips in BHIS broth under conditions that allowed biofilm formation. 
Using scanning electron microscopy (SEM), we show three distinct stages of biofilm formation: initial attach-
ment of bacteria to an abiotic surface via bacterial appendages, through to early biofilm formation, where we 
observe formation of a matrix, culminating at late biofilm formation, in which the bacteria appear to be encased 
within an extracellular matrix (Fig. 1 a and Supplementary Fig. S1 online). Late biofilms formed in static TC 
flasks, were detached after a 72 h incubation from the abiotic surface (bottom) by gentle agitation, fixed and 
transferred onto coverslips for SEM imaging (Fig. 1c). The morphology and structure of biofilms formed in static 
TC flasks (Fig. 1c) is similar to biofilms formed directly on coverslips in 24-well plates (Fig. 1b).
Structure of the biofilm matrix. Visualization by confocal microscopy of C. difficile biofilms produced by strains 
630 and R20291 with a FilmTracer Live-Dead stain, revealed the presence of viable and non-viable cells, encased 
within an extracellular matrix (Supplementary Fig. S2a online). Nucleic acid and less abundant protein com-
ponents within the extracellular matrix were positively stained with Acridine Orange, DAPI and SYPRO-Ruby 
Matrix stain respectively (Supplementary Fig. S2a online). Late biofilms were disrupted with the addition of 
DNase and visualized by DAPI staining (Supplementary Fig. S2b online). The concentration of eDNA alone and 
total DNA (intracellular and eDNA) was significantly less in biofilms formed by R20291 (12.7 ± 0.7 mg/biofilm) 
compared to 630 (18.5 ± 1.6 mg/biofilm) (Supplementary Fig. S2c online).
Composition of C. difficile biofilms from representative strains of five lineages. Representatives from all five C. dif‑
ficile lineages produce robust biofilms, however, R20291 (RT027) and M68 (RT017) form biofilms with signifi-
cantly less biomass than 630 (RT012), CD305 (RT023) and M120 (RT078) (Fig. 2a,b). Biofilms from all five C. 
difficile lineages contain eDNA in their matrix (Fig. 2c), however, the concentration of eDNA correlated directly 
with biofilm biomass: strains R20291 (RT027) and M68 (RT017) contain significantly less eDNA in their matrix 
than 630 (RT012) (p < 0.05 and p < 0.01 respectively) (Fig. 2c; Table 2). Biofilms produced by all five C. difficile 
lineages in TC flasks were degraded by the addition of exogenous DNase (Fig. 2e), indicating that eDNA is an 
integral part of the biofilm matrix for all five lineages. We detected and quantified vegetative cells and spores 
encased within the biofilm matrix, compared to the planktonic phase from all five lineages (Supplementary 
Fig. S3 online). We observed a similar sporulation frequency in the biofilm matrix of strains CD305 (RT023) 
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(42.6% ± 12.1) and M120 (RT078) (49.7% ± 7.3) compared to 630 (RT012) (37.1% ± 9.6) (Fig. 2d). Conversely, 
we observed a significant reduction in the percentage sporulation within the biofilm matrix of strains R20291 
(RT027) (14.5% ± 3.7) and M68 (RT017 (Fig. 2d) (15.0% ± 1.43), compared to 630 (p < 0.01), which is linked 
to reduced eDNA concentration within the biofilm matrix (p < 0.01) and decreased biofilm biomass (p < 0.01) 
(Fig.  2). Overall, we observed a significant increase in spore titre (p < 0.01) within the biofilm matrix com-
pared to the planktonic phase (supernatant) for all strains with the exception of CD305 (Supplementary Fig. S3 
online), where the sporulation frequency is similar in both the planktonic culture and biofilm. All five C. difficile 
lineages exhibit a positive correlation between biofilm biomass, eDNA concentration and percentage sporula-
tion within the biofilm matrix (Fig. 2).
The role of cell surface proteins in early biofilm formation. Clostridioides difficile encodes a number 
of cell surface proteins, either non-covalently anchored to the cell wall or covalently anchored to peptidoglycan 
via sortase  SrtB48–51. A number of cell wall associated proteins are regulated by the secondary messenger c-di-
GMP. We therefore investigated the impact of c-di-GMP and sortase substrates of C. difficile on biofilm forma-
tion.
The effect of the secondary messenger c‑di‑GMP on attachment and biofilm formation. C-di-GMP has been 
shown to promote biofilm  formation42,44,53. In order to investigate whether elevated levels of c-di-GMP altered 
attachment, early biofilm (24 h) or late biofilm formation (72 h), we used C. difficile strain 630 harbouring a 
plasmid encoding the diguanylate cyclase gene dccA under the transcriptional control of an anhydrotetracycline 
(ATc) inducible promoter (Ptet)49. In line with Purcell et al.44,57, we observed a significant increase in early biofilm 
formation (Fig. 3) with induction of dccA (p < 0.001 at 25 ng/mL and p < 0.01 at100 ng/mL ATc), which elevates 
Figure 1.  A schematic and SEM visualisation of biofilm formation of C. difficile strain 630. (a) visualization of 
three stages of biofilm formation grown on coverslips in 24-well plates for 16 h (attachment), 24 h (early biofilm) 
and 72 h (late biofilms) prior to visualization. Surface attached appendages are indicated with an arrow, within 
the white box. White boxes indicate high magnification images present in supplementary data (Supplementary 
Fig. S1 online). Scale bar 5 µm. (b,c) Comparison of late biofilms formed on coverslips in 24 well plates and 
in tissue culture flasks, fixed and transferred to a stub for imaging. (b) Scale bar 10 µm (×1000), 5 µm (×3500 
and ×5000), (c) scale bar 100 µm (×150), 10 µm (×1000 and ×3000).
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c-di-GMP. There was no significant difference in the effect of c-di-GMP on late biofilm formation or initial 
attachment and no significant modulatory effect of exogenous anhydrotetracycline added to control cells, at any 
stage of biofilm formation (Fig. 3). This indicates that the significant increases in biofilm biomass observed dur-
ing early biofilm formation were due to c-di-GMP induction.
The role of PPEP‑1 cleaved cell surface proteins in early biofilm formation. Surface exposure of the sorted pro-
teins CD2831 and CD3246 is tightly controlled by a c-di-GMP dependent pathway, via a type II riboswitch, 
summarized in Fig. 4A. There is an inverse transcriptional regulation of CD2831 and CD3246 with the metal-
loprotease PPEP-1, which is under the control of a c-di-GMP dependent type I riboswitch (Fig. 4A). Elevated 
c-di-GMP increases expression of surface localized  CD283149 and CD3246  proteins54,55. Gene inactivation of 
CD2831 (Supplementary Fig. S4 online) significantly reduced early biofilm formation (p < 0.05, Fig. 5B), which is 
complemented in trans with the addition of CD2831 under the control of an anhydrotetracycline (ATc) inducible 
promoter (Fig. 4B). In-frame deletion of PPEP‑1 does not significantly alter early biofilm formation (Fig. 4C), 
however, over-expression of CD2831 or CD3246 in a PPEP‑1 mutant significantly enhances early biofilm for-
mation (p < 0.01, p < 0.05 respectively, Fig. 4C). This suggests that CD2831 and CD3246 are important in early 
Figure 2.  Biofilm formation and eDNA concentrations of representative strains from each of the five C. difficile 
lineages. (a) Biofilm biomass determined by crystal violet assays performed in 24-well plates. (b) Quantification 
of biofilm biomass by methanol extraction of crystal violet assays performed in 24-well plates. Crystal violet 
assays are representative of six independent biological replicates. (c) Concentration of eDNA (C. difficile cells 
and spores were removed prior to eDNA quantification by filtering the vortexed disrupted biofilm samples) 
from duplicate biofilms produced in 24-well plates compared to TC flasks in a representative strain of all five 
C. difficile lineages: 630 (RT012), R20291 (RT027), CD305 (RT023), M68 (RT017) and M120 (RT078). (d) 
Percentage sporulation in the biofilm matrix produced in TC flasks for each strain in biological triplicates. 
(e) Duplicate late biofilm cultures were grown in tissue culture flasks, then detached by gentle agitation from 
the bottom of the tissue culture flask. One was left untreated and the other treated with 100 µg/mL DNase for 
15 min to disrupt the biofilm matrix. Images of the tissue culture flasks were taken with a Cannon 600D SLR 
(mounted on a copy stand with lighting unit (Kaiser RS2) with a 50 mm prime lens). This was undertaken 
for C. difficile strains from all five lineages: 630 (RT012), R20291 (RT027), M120 (RT078), M68 (RT017) and 
CD305 (RT023). All error bars are SD. Statistical differences were assessed using linear regression analysis and 
significant differences are indicated *p < 0.05, **p < 0.01, ***p < 0.001.
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biofilm formation in the presence of high levels of c-di-GMP, when expression of the peptidase PPEP-1 would be 
low, as this would result in CD2831 and CD3246 remaining attached to the cell wall of C. difficile. 
The role of additional cell surface proteins in early biofilm formation. Using gene inactivation mutagenesis, we 
studied the roles of other cell wall proteins in biofilm formation. CD3392 is a sortase substrate and is covalently 
anchored to the cell  wall52,54,55. CD0183 contains the canonical (S/P)PXTG motif, but is not processed by sortase 
and is partially bound to the cell wall, presumably by non-covalent  interactions49,50. CD3145 (CbpA) carries an 
LPXTG-like cell wall anchoring domain, but is not processed by  sortase52, however it is expressed on the cell 
surface and binds collagens I and V with high  affinity58.
Mutation of CD3392 or CD0183 significantly reduces early biofilm formation (p < 0.01, Fig. 5a), which is 
complemented by CD3392 or CD0183 expression, in trans (Fig. 5a). Mutation of CD3145 (CbpA), also signifi-
cantly reduced biofilm formation, however, this phenotype was not successfully complemented with expression 
of cbpA in trans (Fig. 5a).
We then asked whether CD3392 could be detected within the biofilm matrix (Fig. 5b). We separated the 
biofilm matrix from the planktonic fraction (culture supernatant) of biofilms grown in TC flasks (Fig. 6a). The 
biofilm matrix fraction was disrupted by DNase treatment and both the matrix and supernatant fractions were 
filtered to remove C. difficile cells prior to SDS-PAGE and western blotting. We identified CD3392 predominantly 
in the matrix fraction of C. difficile cultures, with none detectable in the planktonic fraction (Fig. 5b). CD3392 
was not detected in the matrix from a mutant strain, but was present in large amounts in the matrix from a 
complemented strain, suggesting CD3392 may form part of the biofilm matrix.
Detection of matrix proteins. To identify further proteins in the matrix, biofilms were produced in TC flasks 
and the biofilm matrix fraction was separated from the planktonic fraction (culture supernatant) (Fig. 6a). The 
biofilm matrix fraction was disrupted by (1) vortexing prior to quantification by BCA assay, or (2) by DNase 
treatment prior to SDS-PAGE analysis. After disruption of the biofilm matrix, aliquots from both the matrix and 
supernatant fractions were filtered to remove C. difficile cells before analysis was undertaken. We performed 
LC–MS/MS on the four main bands identified by SDS-PAGE as unique to the filtered biofilm matrix from C. dif‑
ficile strain 630∆erm (Fig. 6b). These four bands analysed were also present in the biofilm matrix of the CD3392 
mutant and complement strains, indicating their potential importance in biofilm formation (Fig. 6). Analysis of 
these bands indicate the presence of multiple C. difficile proteins: 12 proteins in band 1, 5 proteins in band 2, 13 
proteins in band 3 and 10 proteins in band 4 (Fig. 6c). The predominant band present in the matrix fraction (1) 
was a combination of the low molecular weight (LMW) portion of the major surface layer protein SlpA, with 
intracellular proteins, which include those involved in butyrate fermentation (Hbd, Buk and ThlA1), oxygen 
stress tolerance (Rbr), amino acid degradation (GluD) and the utilization of glutamate and proline by Stickland 
fermentation (PrdA) (Fig. 6; Supplemenatry Table S1). Alongside these C. difficile proteins, bovine DNase used 
to disrupt the biofilm was also detected in Band 1. The other three bands unique to the biofilm matrix (2, 3 and 
4) were composed of a combination of C. difficile proteins, including; cell surface proteins (FbpA, Cwp19, Cwp6, 
CD1131, SlpA), pathogenicity and adaption proteins (PotA and ModA (ABC transporters)), Rbr (Rubrerythrin) 
and DnaK (chaperone), a phage protein, and proteins involved in amino acid metabolism (proline), fermenta-
Figure 3.  The effect of the secondary messenger c-di-GMP on biofilm formation for C. difficile strain 630. 
In-vitro attachment, early biofilm and late biofilm formation in 24 well plates were quantified using crystal 
violet assays with strains of C. difficile 630 containing an empty plasmid (630 vector), or with a plasmid-based 
diguanylate cyclase (dccA) under control of a Ptet (inducible) promoter. These were compared to a 630 control 
strain containing a plasmid in the presence of 100 ng/mL anhydrotetracycline (630 vector + ATc). Biofilm and 
attachment assays were performed with a minimum of biological quadruplicate. The concentration of ATc used 
to induce dccA is listed in the graphs (0, 25 or 100 ng/mL), strain labelled  630Ptet dccA 0 is an uninduced vector 
control. Error bars are SD. Significant differences are calculated using linear regression analysis compared to the 
uninduced control strain  630Ptet dccA 0, **p < 0.01, ***p < 0.001.
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tion (butyrate) and phosphoenolpyruvate-dependent sugar phosphotransferase system (PTS) (Supplemenatry 
Table S1; Fig. 6).
Biofilm disassembly and resistance to vancomycin. DNase both inhibited biofilm production and 
disassembled preformed biofilm in TC flasks and on coverslips, whereas Proteinase K partially disrupted pre-
formed biofilms. In contrast, bovine serum albumin had no measurable effect on biofilm initiation and RNase 
did not influence biofilm integrity (Supplementary Fig. S5 online). Therefore, we assessed the effects of the bio-
film dispersal agents, DNase and Proteinase K on the vulnerability of vegetative cells and spores to the antibiotic 
vancomycin (Fig. 7), by comparing the viable counts of vegetative cells and spores within intact and disrupted 
biofilms in the presence of vancomycin. We observed that vancomycin alone significantly reduced the viable 
vegetative cell count in intact biofilms (p < 0.01 COV = − 6.243) to 7.7% of the untreated level, whereas disrup-
tion with DNase (p < 0.01 COV = − 10.805) combined with vancomycin treatment reduced the vegetative cell 
count to 0.68% of the untreated control. However, treatment with proteinase K in combination with vancomycin 
Figure 4.  The effect of c-di-GMP regulated cell wall proteins on biofilm formation for C. difficile strain 630. 
(a) Schematic showing the sortase-dependent anchoring of CD2831 to the peptidoglycan of C. difficile. Under 
high levels of c-di-GMP, CD2831 is expressed by the permissive interaction of c-di-GMP with the upstream 
type II riboswitch (Cdi2_3). The protease PPEP‑1 is repressed under high levels of c-di-GMP due to the 
upstream type I riboswitch (Cdi1_12). Under low levels of c-di-GMP, expression of CD2831 is repressed and 
PPEP‑1 is upregulated, resulting in the cleavage of CD2831 (and CD3246) from the peptidoglycan and release 
into the supernatant. This scheme is based on published  data49,55,56. (b) Crystal violet quantification of early 
biofilm formation produced in 24 well plates with an insertional inactivation mutant of CD2831 compared 
to its wildtype and inducible CD2831complement under control of anhydrotetracycline (ATc). (c) Crystal 
violet quantification of early biofilm formation produced in 24 well plates with overexpression of CD2831 and 
CD3246 under the control of an ATc inducible promoter, in an in-frame deletion mutant of the protease PPEP‑1. 
Crystal violet assays were performed with a minimum of 6 biological replicates. Error bars are SD. Significant 
differences are calculated using linear regression analysis compared to all strains against its respective parent 
strain 630Δerm or 630, *p < 0.05, **p < 0.01.
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treatment only reduced the viable vegetative cell counts to 72.8% of an untreated biofilm (p = 0.916 COV = − 
0.309) (Table 2), which was less effective than the addition of vancomycin alone, suggesting that proteinase K 
may affect the structural integrity of the glycopeptide antibiotic vancomycin, thus reducing its potency. This 
indicates that the combined effect of DNase and vancomycin produced the most significant reduction in viable 
vegetative cell counts. As expected, vancomycin had no effect on spore viability irrespective of biofilm disrup-
tion, compared to the untreated biofilms (Fig. 7a; Table 2). The addition of DNase alone had no effect on vegeta-
tive cells (p = 0.989, COV = 0.010) viability, however DNase had a small but significant effect on spore viability in 
the biofilm matrix (p < 0.05 COV = − 0.568) (Fig. 7b) and the planktonic fraction p < 0.01 (Supplementary Fig. S6 
online). The addition of proteinase K alone had no effect on the viability of vegetative cells (p = 0.897 COV = − 
0.086) or spores (p = 0.109, COV = 0.437) compared to the untreated biofilms (Fig. 7b). However, proteinase K 
decreased the relative proportion of spores (p < 0.05, COV = − 0.494) in the presence of vancomycin (Fig. 7a; 
Table 2) compared to the vancomycin treated biofilms, suggesting that proteinase K reduced the spores’ viability 
only in the presence of vancomycin. This adds additional evidence to the protective nature of the biofilm and the 
efficacy of DNase to disrupt the biofilm and reduce spore viability. Additionally, when used in combination with 
a current first line therapy DNase promotes the efficacy of vancomycin to reduce the viability of vegetative cells.
Discussion
In this study, we identify several factors involved in biofilm formation in all five C. difficile lineages, as well as 
exogenous factors involved in biofilm disassembly, which enhance the efficacy of vancomycin, a first line anti 
C. difficile treatment (summarized in Supplementary Fig. S7 online). A greater understanding of biofilm forma-
tion, dispersal and inhibition in other pathogenic bacteria has reduced disease burden and prevented relapse of 
 infections59. Many patients suffer from long lasting chronic infections, driven by bacteria persisting in biofilms 
or other protected niches, impenetrable or intrinsically resistant to antibiotic  therapy7,60. The current crisis in 
widespread antimicrobial resistance has raised fears over an era of untreatable  infections61.
The purpose of a biofilm matrix is aligned within and between bacterial species to protect the cells encased 
therein from environmental stresses, antibiotics and the immune  response6. Interestingly, several bacterial spe-
cies modulate their biofilm matrix composition between (1) exopolysaccharide, (2) extracellular and cell surface 
proteins and (3) extracellular DNA (eDNA)13: The human pathogens S. aureus and P. aeruginosa produce multiple 
distinct biofilm matrix  compositions19,62. In S. aureus, biofilm composition can be proteinaceous (cell surface 
proteins and teichoic acid) combined with eDNA or alternatively a specifically synthesized exopolysaccharide 
[β-1,6-linked N-acetylglucosamine (PIA/PNAG)]45,63, yet the clinical importance of these two variants is not 
completely  understood19. Combinations of eDNA, proteins and polysaccharides have been identified surrounding 
adherent colonies of C. difficile, although the extent to which they contribute to biofilm formation and integrity 
remains to be  determined24,25. In this study, we show that clinical strains representing each of the five C. difficile 
lineages RT012 (630), RT027 (R20291), RT023 (CD305), RT017 (M68) and RT078 (M120) produce biofilms on 
Figure 5.  Cell wall proteins involved in biofilm formation. (a) Insertional inactivation mutants of non-c-di-
GMP regulated proteins CD0183, CD3145 and CD3392 were created in C. difficile strain 630Δerm. Mutants 
were complemented by introduction of plasmids expressing the wild type gene. These mutants and their 
complements were assessed for their ability to form early biofilms (24 h) on an abiotic surface in vitro compared 
to a wild-type control. Crystal violet assays were performed with a minimum of 6 biological replicates. All 
error bars are SD. Statistical differences were assessed using linear regression to compared to all strains against 
their respective parent strain 630Δerm, *p < 0.05, **p < 0.01, ***p < 0.001. (b) Western blot using anti CD3392 
antibodies of the matrix (M) and planktonic fractions (P) of a late biofilm, from strains 630Δerm, CD3392::CT 
and CD3392 complement (CD3392::CT (pCD3392)). The biofilm matrix was detached from the bottom of a TC 
flask, disrupted by the addition of DNase (100 µg/mL), then loaded onto an SDS-PAGE gel alongside a protein 
ladder (L) for analysis by Western blot.
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an abiotic surface, comprised of vegetative cells and spores encased within an EPS matrix comprised mainly of 
eDNA combined with intracellular and cell surface associated proteins.
In P. aeruginosa, temporal and genetic control of eDNA release by cell lysis is essential in initial development 
of biofilm  formation18,20 and for many pathogenic bacteria, including P. aeruginosa, Enterococcus faecalis and 
L. monocytogenes DNA is a major component of the biofilm  matrix18,21,64,65. In this study, we show that biofilm 
biomass positively correlates with eDNA concentrations within the biofilm matrix. Representatives of three 
C. difficile lineages, RT012(630), RT023(CD305) and RT078(M120) form larger more robust biofilms with a 
higher eDNA concentration and an increased sporulation frequency within the biofilm matrix, compared to 
representatives of the other two C. difficile lineages, RT027 (R20291) and RT017(M68). We show that without 
DNA, a major component of the biofilm matrix in C. difficile, initial biofilm formation is severely inhibited, and 
late biofilms are disassembled in all five C. difficile lineages. Our data complements a study from Dubois et al., 
who identified eDNA as a component of C. difficile biofilms formed by strain 630∆erm in the presence of the 
secondary bile salt deoxycholate (DOC), which is present in the human gut and toxic to vegetative  cells29. The 
structural importance of eDNA should not be underestimated, in other species eDNA aids bacterial adhesion, 
stabilizes the biofilm structure and contributes to antimicrobial resistance, by chelating cations and restricting 
diffusion of cationic  antimicrobials66. Environmental conditions can trigger alterations in the abundance of 
exopolysaccharides and eDNA within S. aureus biofilms, however, even small quantities of eDNA are essential 
for biofilm  integrity67. Herein, we demonstrate that although there are variations in eDNA concentration within 
Figure 6.  Analysis of the biofilm matrix and planktonic fractions. (a) Separation of the biofilm matrix and 
supernatant (planktonic fraction). After the biofilm matrix was detached from the bottom of the TC flask, the 
biofilm matrix was disrupted by the addition of DNase (100 µg/mL). (b) SDS-PAGE electrophoresis of the 
Biofilm matrix after DNase processing (M), filtered biofilm matrix  (MF), compared to the filtered planktonic 
fraction  (SF), and DNase control. The arrows on the left label the bands (1–4 top to bottom) sent for LC–MS/
MS from strain 630∆erm, the blue arrows indicate the major and minor DNase band within the DNase control 
lanes. (c) Protein classification of the bands 1–4 presented in pie charts, with the percentage normalized total 
spectra. Colour codes indicate different functional classifications in accordance with the Riley classification.
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the biofilm matrix of different C. difficile lineages, eDNA is a key factor in development and structural integrity 
of C. difficile biofilms across all five lineages.
We detected a significantly higher spore titre in the biofilm matrix compared to the planktonic phase for four 
of the five lineages. C. difficile sporulation is linked to persistence of  CDI68,69 and is mediated by the sporula-
tion master regulator spo0A, inactivation of which results in a significant reduction in biofilm  biomass23,25,29, 
indicating a key role for Spo0A in biofilm formation. Biofilms enhance persistence for many chronic bacterial 
infections, providing protection from environmental stresses and  antibiotics60. Therefore, we hypothesise that 
Spo0A may support C. difficile biofilm formation and persistence, by inducing sporulation and consequently 
cell lysis during stationary phase, resulting in a release of eDNA, which can be incorporated into the biofilm 
matrix. Vegetative cells and spore encased within these protective biofilms could be released to re-seed the gut 
and facilitate relapse of CDI.
Biofilm architecture is a key factor of recalcitrance (resistance to antibiotics), which affects drug diffusion, as 
well as initiation of the starvation and SOS response, which all contribute to biofilm  stability7. Biofilms produced 
by different bacterial species can be artificially disrupted by the addition of exogenous polyamines, DNase, 
d-amino acids or alginate lyase depending of the structure and composition of the biofilm  matrix18,71–73. To 
eradicate chronic infections combinatorial approaches that induce biofilm dispersal via enzymatic degradation 
(DNase, Dispersin A or glucanhydrolases) with current antibiotic  therapy7 enhances eradication of pathogens 
such as Streptococcus mutans and P. aeruginosa in cystic fibrosis  patients75. Herein, we show that DNase suc-
cessfully disassembles biofilms produced by all five C. difficile lineages and that degradation of eDNA within the 
biofilm by DNase, increases the effectiveness of vancomycin from 92.3 to 99.3% at reducing vegetative cell titre. 
We show DNase reduced the viability of C. difficile spores in both the biofilm matrix and planktonic fraction, 
measured by germination, which aligns with a study in B. subtilis, showing a combination of lysozyme and DNase 
damaged spore coat proteins affecting viability and  germination76. Dapa et al. observed a decrease in biofilm 
integrity in preformed biofilms with both proteinase K and DNase, with extended  incubation25 and Dubois et al., 
found both DNase and proteinase K dispersed C. difficile biofilms induced in the presence of the secondary bile 
salt  deoxycholate29. However, in our system, proteinase K only marginally reduced biofilm biomass, this poten-
tially results from media differences, as Dubois et al., used BHISG growth media, known to preferentially promote 
exopolysaccharide production and reduce eDNA within a S. aureus  biofilm67. More importantly, we show that 
proteinase K reduced the bactericidal effect of vancomycin on C. difficile, indicating that proteinase K should not 
be used synergistically with vancomycin. This highlights the merits of a dual approach for reducing C. difficile 
biofilm recalcitrance, in which DNase reduces both spore germination and enhances the efficacy of vancomycin.
In many organisms, particularly Gram-negative bacteria, elevated levels of the secondary messenger c-di-
GMP promote biofilm formation by regulating many cellular systems, including biosynthesis of matrix polysac-
charides in P. aeruginosa59,62, E. coli77 and S. aureus45, whereas low level c-di-GMP inhibits biofilm  formation54,78. 
Figure 7.  The effect of vancomycin on CFU counts in disrupted and intact C. difficile strain 630 biofilms. (a) 
The effect of vancomycin treatment alone or in combination with DNase and Proteinase K on both vegetative 
cells and spores within an intact and degraded biofilm was undertaken in 3-day old biofilms, compared to 
untreated 3-day old biofilms. (b) A comparison between the effects of either DNase or proteinase K on the 
viability of vegetative cells and spores within a biofilm. The biofilms were detached from the bottom of the flask 
by gentle agitation and pre-treated with either vancomycin, or vancomycin supplemented with recombinant 
DNase or Proteinase K, compared to an untreated intact biofilm. Total counts and spores were enumerated and 
differentiated by heat inactivation of spore samples, thus killing the vegetative cells, enumerating spores alone. 
Experiments were undertaken with a minimum of 3 biological replicates. The data was analysed in Excel and 
GraphPad Prism 7.0, and error bars represent SD. Statistical analysis to determine the effect of vancomycin 
on disrupted and intact biofilm was performed using linear regression, **p < 0.01 (grey) and the effect of 
vancomycin and vancomycin combined with DNase and Proteinase K compared to untreated biofilms *p < 0.05, 
**p < 0.01, ***p < 0.001 (black).
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Sub-inhibitory concentrations of certain antibiotics trigger an increase of c-di-GMP to promote biofilm forma-
tion in E. coli and P. aeruginosa62,77. C. difficile encodes multiple enzymes involved in the synthesis (diguanylate 
cyclases) and degradation (phosphodiesterases) of c-di-GMP79. In C. difficile, c-di-GMP inversely regulates 
aggregation and cell  motility57, by modulating expression of the flgB flagella  operon43 and the type IV pili  cluster80. 
Herein, we show that c-di-GMP enhances early biofilm formation, corroborating observations from Soutourina 
et al.53 and Purcell et al.44,57, however, c-di-GMP has little effect on attachment and late biofilm formation. Some 
cell wall anchored proteins in C. difficile, including CD2831 and CD3246 are regulated via a c-di-GMP dependent 
pathway, which increases transcription via a type II dependent  riboswitch54. Under elevated c-di-GMP, CD2381 
and CD3246 are covalently attached to peptidoglycan in the cell wall of C. difficile via a sortase enzyme (SrtB)49. 
Conversely, under low level c-di-GMP, PPEP‑1, a metalloprotease (CD2830/ZmpI) controlled by type I dependent 
riboswitch is upregulated and cleaves CD2831 and CD3246 from the cell  wall54. We observed that the cell wall 
protein CD2831 enhances early biofilm formation in C. difficile and overexpression of CD2831 or CD3246 in a 
PPEP‑1 deletion background mimics an elevation of c-di-GMP levels, which results in significantly increased bio-
film formation. Similar to our observations, surface associated cell wall proteins regulated by sortase in S. aureus 
are linked to biofilm  formation47. We speculate that increased biofilm formation under elevated c-di-GMP (in 
trans) in early biofilm formation could result from reduced cleavage of CD2831 and CD3246 from the cell wall, as 
well as promoting expression of c-di-GMP dependent genes, these include cell wall genes, PTS systems and ABC 
transporters, that were identified by McKee et al. as directly or indirectly regulated by c-di-GMP  riboswitches54. 
In line with our results, Arato et al. showed a contribution of CD2831 in biofilm  formation81, whereas Poquet 
et al.28 did not observe a difference in biofilm formation upon deletion of CD2831. However, Poquet et al., used 
BHISG media for biofilm formation, which as discussed, triggers environmental biofilm variants in S. aureus, with 
increased exopolysaccharide formation and reduced  eDNA67. In some species, environmental conditions trigger 
a biofilm matrix preferentially composed of cell surface proteins alongside  eDNA47,82,83. In addition to media, 
differences in biofilm composition in C. difficile observed between laboratories may be a result of variation in 
intrinsic c-di-GMP levels, which regulate the cleavage of CD2831 from the peptidoglycan via PPEP-1. To address 
this, we overexpressed CD2831 and CD3246 in a PPEP‑1 deletion strain and showed a significant increase in 
biofilm formation. We suggest that temporal production of c-di-GMP positively modulates early biofilm forma-
tion, rather than increasing biomass of an established biofilm by modulating attachment of cell wall proteins to 
peptidoglycan, alongside upregulating PTS systems and ABC transporters identified by McKee et al. to modulate 
metabolism within a biofilm and downregulate motility, which favors a sessile lifestyle (Supplementary Fig. S7 
online). Alongside the c-di-GMP regulated cell surface proteins, we also identified non-c-di-GMP regulated 
cell surface proteins which contributed to early biofilm formation in C. difficile, some of which are covalently 
anchored to peptidoglycan via the sortase (StrB)49,50,52. We identified that deletion of the cell surface proteins 
CD0183; a putative cell wall hydrolase, CbpA; a collagen binding protein and CD3392; a predicted collagen bind-
ing protein, significantly reduced the biomass of early biofilms. Several sortase substrates of S. aureus, including 
FnbpA, FnbpB, ClfA and CflB, are known to promote biofilm  formation84. Interestingly, methicillin resistant S. 
aureus (MRSA) forms biofilms with predominantly cell surface proteins and eDNA, whereas methicillin sensitive 
S. aureus (MSSA) forms biofilms with the PIA  exopolysaccharide47. This highlights the role for a combination 
of c-di-GMP dependent and c-di-GMP independent cell surface proteins and eDNA within a biofilm matrix.
We, like Semenyuk et al.85 were unable to identify a specific highly produced exopolysaccharide in the C. 
difficile biofilm matrix. We observed the presence of c-di-GMP dependent and c-di-GMP independent cell wall 
proteins, PTS and ABC transporters, and intracellular proteins within the biofilm matrix of C. difficile, which 
contribute to the biofilm architecture alongside eDNA. There are many parallels identified between the proteins 
we detected in the bands unique to the biofilm matrix compared to those identified by Dubois et al. in response 
to  DOC29 and genes identified as upregulated in biofilm cultures by Poquet et al.28, including the cell surface 
proteins, amino acid metabolism and degradation, and fermentation, particularly butyrate. In S. aureus, posi-
tively charged cytoplasmic  proteins86, eDNA-binding proteins and membrane-attached lipoproteins released 
into the extracellular environment by cell lysis make electrostatic interactions with the negatively charged cell 
surface proteins and eDNA to produce an electrostatic net, enhancing attachment and forming a stable biofilm 
 matrix13,82. We identified the low molecular weight (LMW) cell wall protein SlpA as the most abundant protein 
within the biofilm matrix unique bands, which has been shown to enhance adhesion of vegetative C. difficile cells 
to host epithelial  cells87 and potentially promote biofilm formation. Other proteins identified within the biofilm 
architecture were involved in amino acid fermentation, particularly Stickland fermentation including PrdA, 
which was also upregulated in C. difficile biofilms formed in response to  DOC29. Other matrix proteins were 
involved in nitrogen and glutamate metabolism, including GluD, which facilitates resistance to  H2O2 and found 
in the stool of CDI  patients88 and Buk, involved in butyrate fermentation. Interestingly, we identified proteins 
involved in detoxification, most notably the rubrerythrin protein Rbr, involved in oxidative stress response, which 
complements data from Dubois et al. showing an upregulation of stress associated genes in C. difficile biofilms 
formed in the presence of  DOC29. Other biofilm matrix proteins identified in the four unique bands include the 
chaperone DnaK, which is important in biofilm formation in E. coli89 and C. difficile38. This provides additional 
evidence of the presence of both cell wall and intracellular proteins within the C. difficile biofilm matrix.
There are a number of sources of eDNA and intracellular proteins within biofilms, including autolysis (E. 
faecalis, S. aureus, P. aeruginosa, S. epidermidis)64, phage induced lysis (S. pneumoniae, Shewanella oneidensis)90,91, 
active  secretion66 and extracellular vesicles (OMVs), although the contribution of OMVs to biofilm formation is 
 unclear92. Recent data suggests a role for the autolysin Cwp19 in biofilm formation in C. difficile in the presence 
of  DOC29. Cwp19 has been shown to be involved in autolysis of C. difficile in stationary phase in BHIS  media93. 
We observed Cwp19 and a phage protein (phiCD24-1) by LC–MS analysis of the matrix specific proteins, 
indicating that an autolysin and/or phage mediated cell lysis potentially contributes to the release of eDNA, in 
combination with lysis of sporulating cells driven by Spo0A. Other species such as Cryptococcus neoformans 
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enhance biofilm formation by actively shedding their capsular polysaccharide  glucuronoxylomannan94, there-
fore we could hypothesise that some of the cell surface proteins identified in the biofilm matrix maybe actively 
shed by C. difficile. We could also hypothesize that in a similar way to S. aureus, cytoplasmic proteins released 
during stationary phase may be  recycled86 to form the architecture of the biofilm matrix in combination with 
eDNA and cell surface associated proteins, and that eDNA stabilizes the biofilm structure and contributes to 
antimicrobial resistance.
We show that eDNA is essential for the formation and structural integrity of C. difficile biofilms in all five 
C. difficile lineages, and that there is a positive correlation between biofilm biomass, eDNA and sporulation 
frequency. We hypothesize that the biofilm scaffold, comprised of eDNA, cell wall and intracellular proteins, 
surrounding vegetative cells and spores is most likely a result of cell lysis at stationary phase when C. difficile 
undergoes sporulation driven by the sporulation master regulator Spo0A, in combination with lysis of a sub-
population of cells via Cwp19 or phage mediated autolysis. Biofilms provide a potential reservoir of bacteria and 
spores to re-colonise an individual post-treatment, therefore we present a strategy using DNase to interfere with 
both biofilm initiation, maturation and recalcitrance for C. difficile, which reduces spore viability and promotes 
the efficacy of a current antibiotic therapy, such as vancomycin: which may prove valuable in the treatment of 
C. difficile infection or relapse.
Materials and methods
Growth of bacterial strains. Clostridioides difficile strains used in this study are summarized in 
Table 168,95,96. Strains were cultured on either Brazier’s agar (Bioconnections, Leeds, South Yorkshire, UK) plus 
4% egg-yolk, C. difficile supplement (Bioconnections) and 1% defibrinated horse blood or Brain heart infusion 
media (Oxoid) with 0.5% w/v yeast extract (Sigma) and 0.1% l-Cysteine (Sigma) (BHIS). Liquid cultures (pri-
mary cultures) were grown in BHIS broth containing BHI medium (Oxoid) plus yeast extract (0.5%) and 0.1% 
l-Cysteine in vented tissue culture (TC) flasks (25  cm3, Falcon), shaking at 65 rpm for 16 h, these were back 
diluted in pre-reduced media to  OD595nm 0.5 for dilution 1/10 into biofilm assays. All cultures were grown at 37 
ºC in an anaerobic atmosphere (10%  CO2, 10%  H2, 80%  N2) at 37 °C. When required 15 µg/mL thiamphenicol 
was added to retain the plasmid containing an inducible diguanylate cyclase (dccA). Expression of dccA was 
induced with either 25 ng/mL, 50 ng/mL, 100 ng/mL or 250 ng/mL anhydrotetracycline (ATc). This was added 
every 24 h to retain induction.
Gene inactivation in C. difficile. Isogenic mutants were constructed using either the ClosTron or CodA 
system (Table 1; Supplementary Fig. S4 online)49,51,58,95,97–99 in C. difficile strain 630Δerm95 or 630, respectively. 
These mutants were used alongside the previously published CD3145 Clostron mutant and  complement58. For 
the Clostron mutant, the group II Ll.LtrB intron was retargeted to the gene of interest by SOE-PCR as previously 
 described100, with oligonucleotides (listed in Table 1) designed using the Sigma TargetTron website (http://www.
sigma -genos ys.com/targe tron/websi te). PCR products were cloned into HindIII and BsrGI sites of pMTL007C-
E2 to create the plasmids pCD0183, pCD2831, and pCD3392 (Table 1). Retargeted pMTL007C-E2 plasmids were 
transformed into the E. coli conjugation donor strain  CA43497 and transferred into C. difficile strain 630Δerm by 
conjugation then screened for successful mutants as outlined  previously100,101. DNA extracted from potential 
mutants (lincomycin resistant, thiamphenicol sensitive colonies), were screened by PCR and sequenced across 
the insertion/deletion site using gene specific primers or a gene specific primer with EBS universal primer, to 
verify insertion site. Mutants CD3392 and CD2831 were screened by Southern blot. Southern blot analyses were 
performed using AlkPhosDirect Labelling and detection kit (GE Healthcare) and detection reagents, in accord-
ance with the manufacturer’s guidelines and visualised using CDP star (GE Healthcare). Genomic DNA from 
wild type and potential mutants was digested with BbaB1 for the CD2831 screen (Southern band size for the 
mutant 3.8 Kb) or BtgI and Pcil for the CD3392 screen (Southern band size for the mutant 3.5 Kb). The probe was 
produced by PCR using RAM F and R primers (Table 1), from within the group II intron sequence. Mutations 
were complemented on a plasmid as outlined  previously100 (Table 1).
Biofilm formation. Attachment. This assay was performed in 24-well plates pre-equilibrated with 2 mL 
BHIS medium. The plates were incubated under anaerobic conditions for 6 h before inoculation at a 1/10 dilu-
tion with standardized primary cultures (overnight cultures in BHIS broth back diluted to  OD595nm 0.5) of C. 
difficile to optical density readings  OD595 = 0.05 ± 0.01. Three control wells were left blank, without addition of 
bacterial cultures. Thiamphenicol (15 µg/mL) and anhydrotetracycline (25, 50, 100 or 250 ng/mL) were added as 
required. Plates were incubated for 16 h. The plates were then inverted to remove any cells that were not tightly 
attached to the abiotic surface, meaning the majority of the early stage biofilm is removed, leaving only the at-
tached cells. Each well was then washed twice with 1 mL PBS. The liquid was removed by inversion and tapping 
between each step. The plates were allowed to air-dry in the anaerobe cabinet for 10 min before the attached 
cells were stained with 800 µL of 0.1% crystal violet for 30 min. Plates were washed four times with 1 mL PBS, 
inverting plates between each step, and the crystal violet was solubilized with 1 mL methanol. Attachment was 
determined using  OD595 readings, with a subtraction of the mean of three blanks present on each individual 
plate. Assays were performed with a minimum of six independent replicates. The data was analysed in Excel and 
GraphPad prism 7.0. Statistical analysis was performed (see below).
Early biofilm formation. Biofilms were produced by inoculating overnight cultures of C. difficile into 24-well 
plates containing 2 mL pre-equilibrated BHIS (+ 0.1% l-Cysteine) per well at  OD595 = 0.05 ± 0.01, with the excep-
tion of three control wells, left un-inoculated. All strains were compared to C. difficile control strain 630, carrying 
a plasmid without dccA. These cultures were incubated statically for 24 h, after which supernatants were carefully 
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E.coli DH5α General cloning New England Biolabs
E. coli CA434 Conjugation donor 97
C. difficile strains
630Δerm Erythromycin-sensitive derivative of wild-type C. difficile 630 98
630Δerm_vector Erythromycin-sensitive derivative of wild-type C. difficile 630 with empty plasmid pLFDempty This study
630 (RT012) Wild type ErmR, virulent and multidrug-resistant PCR ribotype 51
630_vector Wild type ErmR, virulent and multidrug-resistant PCR ribotype containing pLFDempty This study
R20291 (RT027) Clinical isolate, virulent and multidrug-resistant PCR ribotype 98
CD305 (RT023) Clinical isolate 98
M68 (RT017) Clinical isolate 98
M120 (RT078) Clinical isolate—non motile 98
CD630_0183::CT Clostron mutant CD0183-549|550s This study
CD630_2831::CT Clostron mutant CD2831-1962|1963s This study
CD630_3145::CT Clostron mutant CD3145-482|483a 58
CD630_3392::CT Clostron mutant CD3392-840|841s This study
CD0183::CT (pCD0183) Clostron mutant complemented with ptet inducible gene This study
CD2831::CT (pCD2831) Clostron mutant complemented with pcwp2 constitutively expressed Strep-tagged gene This study
CD3145::CT (pCD3145) Clostron mutant complemented with pcwp2 constitutively expressed Strep-tagged gene 58
CD3392::CT (pCD3392) Clostron mutant complemented with pcwp2 constitutively expressed Strep-tagged gene This study
630 pcwp2 dccA C. difficile carying a pRFP144 derivative plasmid carrying Pcwp2-dccA for constitutive expression of DccA
49
630 ptet dccA C. difficile carying a pRFP144 derivative plasmid carrying ptet -dccA for inducible expression of DccA 49
Plasmids Description Source
pCD0183 Retargeted pMTL007C-E2 This study
pCD2831 Retargeted pMTL007C-E2 This study
pCD3392 Retargeted pMTL007C-E2 This study
pRPF144 E. coli‑C. difficile shuttle vector for protein expression. Constitutive Cwp2 promoter (Pcwp2) expressing gusA,TmR (5) This study
pRPF185 E. coli‑C. difficile shuttle vector for protein expression. Anhydrotetracycline inducible promoter (Ptet) expressing gusA, TmR
99
pLFDempty pRPF185 containing ptet, with gusA removed 99
pHAS007 pRPF144 containing the slpA SecA2 secretion signal followed by a Strep II tag and an XhoI site for inser-tion of genes downstream
58
pHAS035 (p0183_comp) pRPF185 containing the coding region of native CD630_0183 This study
pHAS013 (p2831_comp) pHAS007 containing the coding region of CD630_2831 from its signal cleavage site This study
pHAS033 (p3145_comp) pHAS007 containing the coding region of CD630_3145 from its signal cleavage site 58
pHAS025 (p3392_comp) pHAS007 containing the coding region of CD630_3392 from its signal cleavage site This study
pECC12 pRFP144 derivative carrying Pcwp2- dccA with a 3′ His-tag, for constitutive expression of DccA 49
pECC17 pRFP185 derivative carrying Ptet-dccA with a 3′ His-tag, for inducible expression of DccA 49
Primers Sequence Use
RAM-F ACG CGT TAT ATT GAT AAA AAT AAT AAT AGT GGG Identification of the clostron RAM cassette
RAM-R ACG CGT GCG ACT CAT AGA ATT ATT TCC TCC CG Identification of the clostron RAM cassette
CD0183-F GGC GAA GGT TGG TTA GCT ACTAG Screening for CD630_0183 mutants
CD0183-R GAT GTT CTT GGT ATA TTC TTT CCT ACTGC Screening for CD630_0183 mutants
CD2831-F CTT ATA CAT TAA AGG TAA TTA GTA TTG AAG ATAGC Screening for CD630_2831 mutants
CD2831-R CGT ATA GTC TCC CCA ACT TTT ACA TTTG Screening for CD630_2831 mutants
CD3145-F GCT AGA GAA AGT TAG CGC AAT AAT GC Screening for CD630_3145 mutants
CD3145-R CTA TAG TAT CTG CGA AAG TAT TTG ACGC Screening for CD630_3145 mutants
CD3392-F GAA ATG CAA AAC TGC AAA AAA CCT CCAG Screening for CD630_3392 mutants
CD3392-R GAT TGT CTT TGT AAC CCA TGT ACG AG Screening for CD630_3392 mutants
EBS Universal CGA AAT TAG AAA CTT GCG TTC AGT AAAC Screening for clostron mutants
CD0183-comp_F GAG CTC GAA AAT TTT AGG AGG TTT ATCG Complement construction
CD0183-comp_R GGG ATC CTT ATA ATA TTC TTT TTG CTG TAA CAA ATC TTG Complement construction
CD2831-comp_F GGG GCT CGA GTC AGA ATT AGG AGA GAA TAG TCA GAT TCA AAG Complement construction
CD2831-comp_R GGG GAT CCC TAA TTT GTA TTT TTA TTT CTT CTT AAT ACG ATA AGT CCT AC Complement construction
CD3145-comp-F GGG GCT CGA GGA TAC TAT AGA AGA AAG TAC TAA TGC AG Complement construction
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removed with a pipette to not disturb the early biofilm attached to the plate. These biofilms were washed twice 
with 800 µL 1X PBS, before the addition of 800 µL of 0.1% crystal violet. The plates were washed four times 
with 1X PBS and the crystal violet was solubilized with 1 mL methanol. The  OD595 readings were obtained and 
the mean of three blank wells present on each individual plate was subtracted. As required, cultures were sup-
plemented with thiamphenicol and/or anhydrotetracycline (ATc). Biofilm biomass was determined using  OD595 
readings of the methanol solubilized crystal violet. A minimum of six independent replicates were performed. 
The data was analysed in Excel and GraphPad prism 7.0. Statistical analysis was performed (see below).
Late biofilm formation. Biofilms were produced as outlined above but were incubated statically for 72 h to 
enable maturation. As required, media were supplemented with thiamphenicol and/or ATc. Biofilm biomass was 
determined using  OD595 readings of the methanol solubilized crystal violet. The mean  OD595 reading of three 
blank wells present on each individual plate was subtracted from each sample well. A minimum of six independ-
ent replicates were performed. The data was analysed in Excel and GraphPad Prism 7.0. Statistical analysis was 
performed (see below).
Statistical analysis of biofilm biomass. Biofilm formation measured by crystal violet assays outlined above was 
assessed using a Students t test or Linear Regression Analysis in Stata IC  1523. For linear regression, the data was 
transformed using  log10 to approximate a normal distribution before a Linear Regression and partial F tests were 
performed to answer the following questions:
a) Is there strong evidence that the concentration of eDNA or total DNA contained within a biofilm matrix 
varies between strains? Linear regression was used to determine if there is strong evidence that there are dif-
ferences in eDNA concentration in biofilm biomass linked to strain, where p < 0.05 indicates strong evidence 
a biofilm contains less eDNA or total DNA within the biofilm matrix compared to the control strain (630). 
The coefficient of variance (COV) (used throughout) determines whether this difference is higher (positive 
number) or lower (negative number) than the reference (630) (COV = 0) (Table 2).
b) Is there strong evidence that cell surface proteins play a role in biofilm formation, measured by biofilm 
biomass. Linear regression was used to determine if there is strong evidence that there are differences in 
biofilm biomass taking individual strains into account. A p < 0.05 indicates strong evidence that deletion 
of cell surface genes or overexpression of cell surface genes, affect biofilm biomass, relative to their specific 
wild-type strains (630∆erm or 630). (Table 2).
c) Is there strong evidence that the addition of c-di-GMP influences biofilm biomass in attachment, early biofilm 
or late biofilm formation, compared to the un-induced control strain (630 ptet‑dccA NI). A partial F test was 
performed to determine if c-di-GMP had an effect on biofilm biomass (p < 0.05). Linear regression was used 
to determine if there is strong evidence that differences in biofilm biomass are linked to induction of dccA, 
where a p < 0.05 indicates strong evidence that c-di-GMP levels, driven by induction of dccA affect biofilm 
biomass compared to the control (Table 2).
d) Is there strong evidence that the strain of C. difficile influences biofilm biomass? A partial F test and linear 
regression were performed to determine if there were strain specific differences in biofilm formation using 
representatives of the five C. difficile clades. p < 0.05 indicates strain specific differences (Table 2).
e) Is there strong evidence that there are strain specific differences in vegetative cells and spores between differ-
ent C. difficile lineages compared to strain 630. Is there strong evidence that percentage sporulation within 
a biofilm differs between ribotypes of the five main lineages. Where a p < 0.05 indicates strong evidence of 
strain specific differences in viable cell counts or sporulation frequency.
Structural components of the biofilm matrix.. SDS‑PAGE and Western blot. Primary overnight cul-
tures of 630Δerm, CD3392::CT and the complement CD3392:: (pCD3392) were diluted to  OD595nm 0.5, then 
inoculated 1/10 to give a final  OD595 0.05 ± 0.01 into TC flasks (Falcon), and static biofilm cultures were grown 
for three days (late biofilms) under anaerobic conditions. Carefully without disturbing the biofilm matrix, 1 mL 
of the supernatant (planktonic fraction) was removed from the static biofilm culture and transferred to a 1.5 mL 
microcentrifuge tube, then samples were filter sterilised (0.2 µM filter) to remove viable cells and spores. The 
biofilm matrix was detached from the base of the TC flask by gentle  agitation23 and removed intact using a 1 mL 
pipette tip before being transferred to a fresh 1.5 mL microcentrifuge tube (as outlined in Fig. 6a). The intact 
biofilm matrix was disrupted by digestion with DNase for 15 min at room temperature (R/T) with 10 µg/mL 
DNase I. The planktonic and matrix fractions (obtained using DNase I digestion of the biofilm matrix) were 
visualised on an SDS-PAGE gel (data not shown). In parallel CFU counts were obtained from the planktonic 
and matrix fractions at early biofilm (24 h—planktonic fraction (2.48 × 108 vegetative cells, 1.91 × 104 spores) 
Table 1.  List of strains and primers.
Primers Sequence Use
CD3392-comp-F GGG GCT CGA GGA AAG TAA GCA ATA CTG GAC GGA AAG Complement construction
CD3392-comp-R GGG GGG ATC CTT ATG ATT TCT TCA TTT TAC GGC GTT TAT AAA G Complement construction
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DNA concentration in the biofilm matrix Regression analysis Partial F test
Conditions Strain COV p value p value
Extracellular DNA:
630 0 Reference
R20291 − 0.371 0.038 0.0382
Total DNA:
630 0 Reference
R20291 −0.1 0.53 0.5302
Cell surface proteins Regression analysis Partial F test
Strain COV p value p value
630∆erm 0 Reference




630 ∆PEPP‑1 − 0.09 0.623
630 ∆PEPP‑1::Ptet2831 0.427 0.011
630 ∆PEPP‑1::Ptet3246 0.434 0.029
630∆erm 0 Reference
0.0004
CD0183::CT − 0.979 0.000
CD0183::CT::Ptet0183 − 0.273 0.184
CD3145::CT − 0.453 0.029
CD3145::CT::p3145 − 0.511 0.014
CD3392::CT − 0.64 0.002
CD3392::CT::p3392 − 0.277 0.178
c-di-GMP Strain
Regression analysis Partial F test
COV p value p value
Attachment
630  Ptet-dccA NI 0 Reference
0.1957
630 empty 0.065 0.753
630  Ptet-dccA25 0.163 0.354
630  Ptet-dccA100 − 0.319 0.264
630 vector 0 Reference
0.3339
630 vector + ATc 0.185 0.334
Early biofilm
630  Ptet‑dccA NI 0 Reference
0.0059
630 empty 0.438 0.108
630  Ptet-dccA25 0.910 0.001
630  Ptet-dccA100 0.799 0.004
630 vector 0 Reference
0.4876
630 vector + ATc 0.153 0.488
Mature biofilm
630  Ptet-dccA NI 0 Reference
0.3946
630 empty 0.314 0.538
630  Ptet-dccA25 − 0.538 0.295
630  Ptet-dccA100 − 0.243 0.634
630 vector 0 Reference
0.1047
630 vector + ATc − 0.340 0.105
Biofilm disruption Strain
Regression analysis Partial F test




Control + Vancomycin − 6.243 0.013
DNase + Vancomycin − 10.805 0.000




Control + Vancomycin − 0.09 0.776
DNase + Vancomycin − 0.312 0.330
Proteinase K + vancomycin − 0.585 0.074
Vegetative cells
Control + Vancomycin 0 Reference
0.0020DNase + Vancomycin − 1.662 0.021
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Biofilm disruption Strain
Regression analysis Partial F test
COV p value p value
Spores
Control + Vancomycin 0 Reference
0.0281DNase + Vancomycin − 0.222 0.195




Proteinase K − 0.086 0.897
Spores
Control 0 Reference
0.0142DNase − 0.568 0.050
Proteinase K 0.437 0.109
Five main C. difficile lineages biofilm biomass Regression analysis Partial F test
Strain COV p value p value
630 (RT012) 0 Reference
0.0072
R20291 (RT027) − 0.449 0.050
CD305 (RT023) − 0.671 0.003
M68 (RT017) − 0.026 0.907
M120 (RT078) 0.092 0.746
Total CFU counts in matrix compared to the supernatants Regression analysis Partial F test








































Supernatant − 0.16 0.667
DNA concentration in the biofilm matrix Regression analysis Partial F test
Conditions Strain COV p value p value
24 well plates
630 (RT012) 0 Reference
0.0282
R20291 (RT027) − 0.371 0.050
CD305 (RT023) − 0.168 0.303
M68 (RT017) − 0.735 0.004
M120 (RT078) − 0.345 0.066
TC flasks
630 (RT012) 0 Reference
0.0045
R20291 (RT027) − 0.540 0.039
CD305 (RT023) − 0.163 0.459
M68 (RT017) − 1.194 0.001
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and matrix fraction (2.33 × 105 vegetative cells, 1.17 × 106 spores)) and late biofilm [3 days—planktonic fraction 
(3.94 × 105 vegetative cells, 2.35 × 103 spores) and matrix fraction (2.57 × 105 vegetative cells, 1.78 × 105 spores)]. 
The iBlot 2 Dry Blotting System (Thermofisher) was used for transfer of samples from the SDS-PAGE gel to a 
nitrocellulose membrane (Thermofisher). Transfer stacks were assembled and loaded onto the iBlot according to 
manufacturer’s instructions and transferred for 7 min at 20 V. Following transfer, membranes were washed for 
5 min in 1 × PBS + 0.1% Tween20 then incubated with blocking buffer (1 × PBS + 0.1% Tween20 and 5% skimmed 
milk) for 1 h, at room temperature on a rocking platform (Stuart). Primary antibody (anti-CD3392 antibody) 
was added at 1:250 dilution into fresh blocking buffer and incubated for 1 h. Membranes were washed 3 × 5 min 
with 1 × PBS + 0.1% Tween20 before incubation with the fluorescently label goat anti mouse secondary antibody 
1/5000 at the appropriate dilution, in the dark. The membrane was washed 3 × in 1 × PBS + 0.1% Tween20 before 
visualisation on a LI-COR. Images were scanned at 680 nm and labelled in Photoshop elements to retain image 
resolution.
Protein sample preparation and analysis. Primary overnight cultures of C. difficile strains were diluted to 
 OD595nm 0.5, then inoculated 1/10 to give a final  OD595 0.05 ± 0.01 into TC flasks (Falcon), and static biofilm 
cultures were grown for three days under anaerobic conditions. 1 mL of the supernatant (planktonic fraction) 
was transferred to a 1.5 mL microcentrifuge tube for processing, then the biofilm matrix was detached from the 
base of the TC flask by gentle  agitation23 and removed intact using a 1 mL pipette tip before being transferred to 
a fresh 1.5 mL microcentrifuge tube for processing (Fig. 6a). The biofilm matrix was disrupted by digestion with 
DNase for 15 min at room temperature (R/T) with 10 µg/mL DNase I. The planktonic and matrix samples were 
filter sterilised (0.2 µM filter) to remove viable cells and spores. A duplicate late biofilm (72 h) was processed for 
protein quantification, herein, the supernatant and matrix were separated as outlined above, however, for protein 
quantification the matrix samples were vortexed for 2 min to disrupt the biofilm (without the addition of DNase 
I). The total protein concentration in the planktonic fraction (supernatant) (765 µg/mL) and matrix (793 µg/
mL) fractions were determined using a BCA assay (Pierce BCA assay kit) in accordance with the manufacturer’s 
instructions. The planktonic and matrix fractions (obtained using DNase I digestion of the biofilm matrix) were 
visualised on an SDS-PAGE gel, with a DNase I only control lane (Fig. 6). The four bands unique to the matrix 
fraction were excised and sent for LC–MS/MS analysis (King’s College London, CEMS Proteomics facility) 
(Fig. 6). In-gel reduction, alkylation and digestion with trypsin were performed on the excised gel bands prior 
to subsequent analysis by mass spectrometry. Cysteine residues were reduced with dithiothreitol and derivatized 
by treatment with iodoacetamide to form stable carbamidomethyl derivatives. Trypsin digestion was carried out 
overnight at R/T after initial incubation at 37 °C for 2 h. Peptides were extracted from the gel pieces by a series 
of acetonitrile and aqueous washes. The extract was pooled with the initial supernatant and lyophilised. The 
sample was then re-suspended in 10 μL of resuspension buffer (2% ACN in 0.05% FA) and analysed by LC–MS/
MS. Chromatographic separation was performed using a U3000 UHPLC NanoLC system (ThermoFisherScien-
tific, UK). Peptides were resolved by reversed phase chromatography on a 75 μM C18 column (15 cm length) 
using a three-step linear gradient of 80% acetonitrile in 0.1% formic acid. The gradient was delivered to elute 
the peptides at a flow rate of 250 nL/min over 60 min. The eluate was ionised by electrospray ionisation using 
an Orbitrap Fusion Lumos (ThermoFisherScientific, UK) operating under Xcalibur v4.1.5. The instrument was 
programmed to acquire in automated data-dependent switching mode, selecting precursor ions based on their 
intensity for sequencing by collision-induced fragmentation using a TopN CID method. The MS/MS analyses 
were conducted using collision energy profiles that were chosen based on the mass-to-charge ratio (m/z) and 
the charge state of the peptide. Raw mass spectrometry data were processed into peak list files using Proteome 
Discoverer (ThermoScientific; v2.2). The raw data file was processed and searched using the Mascot search algo-
rithm (v2.6.0; www.matri xscie nce.com) and the Sequest search algorithm (Eng et al.; PMID 24226387) against 
the current All Taxonomy and C. difficile databases from Uniprot, at a stringency threshold of 5% false discovery 
rate (FDR) for protein and peptide and a minimum of one peptide per protein. The Database generated file was 
uploaded into Scaffold 4 (v4.8.7) software (www.prote omeso ftwar e.com) for analysis. This was also repeated for 
Bovine DNase I. The stringency threshold parameters were therefore set to 95% protein, minimum 1 peptide and 
95% peptide. The data from each band was then aligned with a protein classification (Riley classification) and 
processed in Excel (Supplemenatry Table S1). Pie charts were produced to show the percentage representation 
of proteins in the matrix.
Percentage sporulation in the biofilm matrix Regression analysis Partial F test
Conditions Strain COV p value p value
Biofilm matrix
630 (RT012) 0 Reference
R20291 (RT027) − 0.0914 0.000
CD305 (RT023) 0.171 0.584
M68 (RT017) − 0.818 0.008
M120 (RT078) 0.351 0.193 0.0003
Table 2.  Statistical analysis. Showing the Students T test p values, the Partial F test p value for the groups 
analysed by linear regression and linear regression Coefficient of Variance and p values.
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DNA quantification. Primary overnight cultures of C. difficile strains 630, R20291, M120, M68 and CD305 
were back diluted in pre-reduced BHIS + Cysteine to  OD595 0.5 and used to inoculate 1/10 into two matched 
vented tissue culture flasks (Falcon) containing 10 mL fresh BHIS + cysteine, or duplicate 24-well plates (Corn-
ing) with each well containing 2 mL fresh BHIS + cysteine at an inoculum density of  OD595 = 0.05 ± 0.01. These 
cultures were incubated statically for three days. Biofilms were detached from the surface of tissue culture flask 
by gentle agitation (Fig. 6a), after which the intact biofilm was removed with a pipette within a volume of 1 mL 
and transferred to a 2 mL screw cap tube. For the 24-well plates, 1.5 mL of excess liquid was removed, then the 
biofilm was detached from the bottom of the well using a pipette and was re-suspended in 500 μL BHIS broth. 
Biofilms were vortexed to disrupt the biofilm matrix. Matched biofilms were processed in parallel to (1) extract 
matrix eDNA by removal of vegetative cells and spores by passing the disrupted biofilm through a 0.22 µM filter 
or (2) extraction of total DNA (matrix eDNA and intracellular DNA), disrupted biofilm matrix samples were 
transferred to a Lysis Tube B (MP Biomedical) before ribolysing at 6.0 m/s for 45 s using a FastPrep-24 classic 
(MP Biomedicals). Both Matrix eDNA and total DNA samples were then processed and extracted using the 
DNeasy Blood and Tissue Kit (Qiagen), following the manufacturers guidelines for the Purification of Total 
DNA from Animal Blood or Cells. In short, 500 µL of the sample from tissue culture flasks or 200 µL from 
24-well plates were processed with the AL buffer in accordance with the manufacturer’s guidelines. Samples 
were eluted in 100 µL of elution buffer. DNA concentrations were then measured by spectrophotometry using 
a DS-11 FX+ (DeNovix) according to manufacturer’s instructions, and concentrations were normalized to per 
biofilm (mg/biofilm).
Microscopy. Confocal microscopy. Thermanox plastic coated 13 mm coverslips (Fisher) were added to the 
24-well plates containing BHIS media (as appropriate with ± thiamphenicol, ± anhydrotetracycline) prior to in-
oculation with C. difficile at  OD595 0.05 ± 0.01. After 24 or 72 h incubation, the media was carefully removed 
with a pipette and the coverslips were washed once in the wells with 1X PBS, before the addition of: 200 µL of 
Acridine Orange diluted to 1X in PBS (PRO-LAB diagnostics), 200 µL FilmTracer SYPRO Ruby (supplied as 
a 1X solution) (Thermo Fisher), or a drop containing 37.5 ng of 4′,6-diamidine-2′-phenylindole dihydrochlo-
ride (DAPI) Vectashield mounting media (Vector laboratories), or 200 µL of FilmTracer LIVE/DEAD biofilm 
viability kit, containing 4.45 nM Syto9 and 13 nM Propidium iodide (Life Technologies) onto the coverslips 
inside the wells and incubated for 30 min. Excess stain was removed and washed twice with 1X PBS. The stained 
thermanox coverslips were mounted face up onto glass slides, with 10 µL 30% glycerol under a glass coverslip 
(22 mm × 22 mm), sealed with clear nail varnish. Slides were visualised under oil immersion (40× and 100× ob-
jectives) using a laser confocal microscope (LSM510 Zeiss microscope). The excitation/emission used for these 
dyes were 543 nm/> 560 nm for Acridine orange, 358 nm/> 461 nm DAPI and FilmTracer LIVE/DEAD stain 
used 488 nm/> 560 nm (SYTO9) and 543 nm/> 650 nm (Propidium Iodide). Acridine orange was scanned at 
both the green (488 nm/> 560 nm) and red (543 nm/> 650 nm), as Acridine orange stains double stranded DNA 
green and ssDNA/RNA red. Z-stacks were performed to measure the biofilm depth. The assays were performed 
with a minimum of quadruplicate independent replicates, imaging a minimum of three fields of view per slide 
and images were analysed using Zeiss LSM image browser and Volocity imaging software.
Scanning electron microscopy. Triplicate independent 2  mL liquid cultures of 630 (in BHIS + cysteine) were 
inoculated into pre-equilibrated low evaporation lid 24-well plates (Nunc) containing Thermanox coverslips 
(Fisher), including two blank media controls. The plates were sealed with Nescofilm and incubated statically at 
37 °C as outlined above. Coverslips were processed at 16 h, 24 h and 72 h for attachment, early biofilm forma-
tion and late biofilm formation, respectively. Coverslips were washed in 1X PBS before fixation. Alternatively, 
late biofilms were detached from the bottom of a TC flask, the biofilm was carefully extracted using a pipette 
(Fig. 6a), then added directly into 1 mL fixative before being transferred to a coverslip and stub for SEM imag-
ing. The fixative was applied to coverslips or late biofilms, 1 mL fixative (2.5% Paraformaldehyde/2.5% Gluta-
raldehyde/0.1 M Sodium cacodylate pH 7.4) was added to each sample, including the media blank controls. 
The samples were washed in 0.1 M Na cacodylate, post-fixed in 1% aqueous/0.1 M Na cacodylate, and stored in 
MilliQ water overnight at 4 °C. These were then air dried and mounted onto an aluminium stub prior to sputter 
coating with gold. Samples were imaged using a JSM35 Scanning Electron Microscope. A minimum of three 
fields of view were imaged per slide at 1× K, 3.5× K, 5× K, 7× K and 10× K magnification for the biofilms grown 
on coverslips in 24-well plates. For the biofilms grown in TC flasks the samples were images at 150×, 1× K and 
3× K and 10× K on a Scanning Electron Microscope.
Inhibition and degradation of biofilms. Degradation of biofilms. Liquid cultures of C. difficile strains 
630∆erm, 630, R20291, CD305, M120 and M68 were incubated in TC flasks under anaerobic conditions for 72 h 
as outlined above, then were removed from the anaerobe hood. The biofilms were detached from the bottom 
of the flask by gentle agitation. These intact biofilms were treated with 1 mg/mL and 100 µg/mL Recombinant 
DNase (Sigma) (10 mg stock dilutions were made in 0.15 M  NaCl2), 1 mg/mL and 100 µg/mL RNase A (Sigma) 
(dilutions were made in nuclease free  dH20) or 1 mg/mL Proteinase K (Qiagen) (stock 20 mg/mL). Samples 
were incubated at R/T for 15 min. Before and after addition of the DNase, RNase or Proteinase K, images were 
taken using a Canon 600D SLR (50 mm prime lens), mounted on a Kaiser RS2 copy stand with lighting unit. 
Late biofilms produced on Thermanox coverslips as outlined above were incubated for 15 min with DNase (1, 
10, 100 µg/mL and 1 mg/mL). The slides were processed for confocal microscopy using FilmTracer LIVE/DEAD 
biofilm viability kit as outlined above.
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Inhibition of biofilm formation. Cultures of C. difficile strain 630∆erm were inoculated at  OD595 0.05 ± 0.01 as 
outlined above into TC flasks (Falcon) containing BHIS media with recombinant DNase (500 µg/mL or 1 mg/
mL final concentration) as outlined above. Images were taken of the 72-h cultures flasks as outlined above.
The effect of vancomycin on CFU counts in disrupted and intact biofilms. The effect of vancomycin treatment on 
both vegetative cells and spores within an intact and degraded biofilm was undertaken in 3-day old biofilms. The 
biofilms were detached from the bottom of the flask by gentle agitation. These intact biofilms were treated with 
either 1 mg/mL recombinant DNase (Sigma), 1 mg/mL Proteinase K (PK) (Qiagen), 12.5 mg/mL Vancomycin, 
or a combination of these, compared to an untreated intact biofilm. Samples were incubated for 24 h at 37 °C 
in an anaerobic atmosphere. Samples were then pelleted by centrifugation at 4500×g for 10 min. Pellets were 
washed twice in 10 mL sterile PBS, then pelleted and re-suspended in 1 mL of 1× PBS and vortexed to break 
down any remaining intact biofilm. Total counts were obtained from 1 mL of each disrupted biofilm culture, 
serially diluted in 1× PBS and plated in triplicate onto BHIS plates supplemented with 0.1% taurocholate. Spores 
were isolated from total cells by heat inactivating 1 mL of each sample (65 °C for 25 min), killing the vegeta-
tive cells, and were plated in triplicate onto BHIS agar plus 0.1% sodium taurocholate. The data was analysed 
in Excel and GraphPad Prism 7.0. Regression analysis was performed to identify significant differences in total 
cell counts and spore counts caused by exposure to vancomycin in disrupted versus intact biofilms (see below).
Statistical analysis of the effect of vancomycin on the CFU counts. The CFU data were transformed using  log10 to 
approximate a normal distribution, after which a linear regression analysis was performed to determine whether 
there was strong evidence that disruption of biofilms increased the vancomycin susceptibility of the vegetative 
cells and spores encased within compared to the intact biofilm. Analysis was undertaken to answer if there: 
were differences in viability of the vegetative cells (1) or spores (2) in the presence of vancomycin in intact and 
DNase or PK disrupted biofilms compared to the untreated biofilm control? These analyses were repeated to see 
if DNase and PK treatment of the biofilms made the (3) vegetative cells or (4) spores more susceptible to van-
comycin than the non-disrupted vancomycin treated control. For all the analyses p < 0.05 indicates a significant 
difference and the coefficient (C) determines whether this difference is higher (positive number) or lower (nega-
tive number) than the reference (indicated in Table 2) (C = 0).
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